Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 2,819.30
-0.70 (-0.02%)
Aug 21, 2026, 3:29 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 465.09 billion as of August 21, 2026. Its market cap has increased by 45.24% in one year.
Market Cap
465.09B
Enterprise Value
434.34B
Revenue
67.25B
Ranking
n/a
PE Ratio
41.21
Stock Price
2,819.30
ChartMarket Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 465.09B, an increase of 56.54%. That is a compound annual growth rate of 8.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 465.09B | 63.93% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.12T |
| Mankind Pharma | 984.58B |
| Laurus Labs | 973.64B |
| Aurobindo Pharma | 932.86B |
| Glenmark Pharmaceuticals | 654.11B |
| Alkem Laboratories | 645.65B |
| Ipca Laboratories | 484.88B |
| Ajanta Pharma | 454.74B |